Skip to main content
. 2017 Jun 8;11:1089–1097. doi: 10.2147/OPTH.S131830

Figure 1.

Figure 1

Patient disposition.

Notes: aDue to adverse events not related to the drug, n (%): olopatadine HCl 0.77%, 4 (2.4); vehicle, 1 (0.9).